Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.

NCT: NCT05223790 · COMPLETED

NCT IDNCT05223790
StatusCOMPLETED
Start Date2022-04-21
Completion2025-01-13

Brief Summary

The Newborn Infant Parasympathetic Evaluation (NIPE) was developed as a method of analysis of the heart rate variability. The monitor gives a value between 0 (low value of the parasympathetic component) and 100 (high value of the parasympathetic component). So far, the measure of the heart failure variability by using the NIPE in infant born very premature ventilated and sedated in neonatal reanimation has not been realised and validated as an evaluation method of the pain and discomfort related to neonatal care.

Frequently Asked Questions

What is Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.?

Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation. is a clinical trial registered under NCT05223790. Current status: COMPLETED.

What is the status of NCT05223790?

The current status of NCT05223790 (Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.) is: COMPLETED.

When did Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation. start?

Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation. started on 2022-04-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑